首页 › 基金 › MAK CAPITAL ONE LLC › ANNX

MAK CAPITAL ONE LLC 对 ANNX 的持仓历史

ANNEXON INC · 医疗保健

MAK CAPITAL ONE LLC 在 Q3 2026 的 13F 申报中披露持有 ANNX(ANNEXON INC)7,769,003 股,市值约 US$32.9M,约占其申报组合的 5.25%,在其申报持仓中市值排名第 7 位。 MAK CAPITAL ONE LLC 最近 4 个申报季度中有 4 个季度披露了 ANNX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)7.77M 股
申报持仓市值$32.86M
组合权重5.25%
首次申报Q4 2025
最近变动增持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

MAK CAPITAL ONE LLC 对 ANNX 的持仓演变

MAK CAPITAL ONE LLC 于 Q4 2025 首次披露 ANNX 持仓:2,958,527 股(约 US$14.9M)。 该持仓在 Q2 2026 达到峰值 5,862,180 股,市值约 US$33.5M。 在 4 次申报中,MAK CAPITAL ONE LLC 3 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 7,769,003 股、市值约 US$32.9M,环比增持 1,906,823 股。。 持仓曾出现大幅变动:Q1 2026 增持约 60% (随后一个季度股价上涨 3%)、Q3 2026 增持约 33% (随后一个季度股价下跌 16%)。

逐季持仓明细

季度股数金额变化
Q4 2025 2.96M $14.85M 新进
Q1 2026 4.72M $26.17M 增持
Q2 2026 5.86M $33.47M 增持
Q3 2026 7.77M $32.86M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ANNX 与 13F 数据

ANNX(ANNEXON INC)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 ANNX,申报仓位最大的包括:Redmile Group, LLC (US$60.4M), BVF INC/IL (US$35.0M), Bain Capital Life Sciences Investors, LLC (US$18.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ANNX 的基金

查看 ANNX 的全部基金持有人 →

常见问题

How long has MAK CAPITAL ONE LLC held ANNX?

MAK CAPITAL ONE LLC has disclosed ANNX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is MAK CAPITAL ONE LLC's current position in ANNX?

As of Q3 2026, MAK CAPITAL ONE LLC holds 7.77M shares of ANNX (ANNEXON INC), valued at $32.86M, representing 5.25% of its reported portfolio and ranking #7.

Has MAK CAPITAL ONE LLC been buying or selling ANNX?

In the latest 13F filing (Q3 2026), MAK CAPITAL ONE LLC increased its position in ANNX. The position peaked in Q2 2026 at 5.86M shares.

Which other funds hold ANNX?

Other major institutional holders of ANNX include Redmile Group, LLC, BVF INC/IL, Bain Capital Life Sciences Investors, LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.